Physician profile
Christopher Michael Clark
NPI 1912341892
$3,886.05
in general payments reported to CMS, 2019-2025
27 companies · $1,345 in 2025
The $1,345 reported for 2025 was more than what 85% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.74 · 2020: $195 · 2021: $490 · 2022: $654 · 2023: $389 · 2024: $737 · 2025: $1,345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,372 · Education: $99.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,372.01 |
| Education | $99.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $886.71 | 2021-2025 | Inspire |
| Glaxosmithkline, LLC. | $656.18 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $589.15 | 2019-2025 | Dupixent |
| Genzyme Corporation | $371.79 | 2022-2025 | |
| Stryker Corporation | $294.11 | 2019-2025 | Scopis Ent |
| Optinose US, INC. | $193.66 | 2019-2025 | |
| Pfizer INC. | $135.87 | 2023-2025 | |
| Abbvie INC. | $89.31 | 2025 | |
| Intersect Ent, INC. | $75.13 | 2020-2021 | |
| Amgen INC. | $58.86 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $46.90 | 2025 | Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $46.08 | 2025 | Glassia |
| Merck Sharp & Dohme LLC | $41.57 | 2021-2023 | |
| Aroa Biosurgery Incorporated | $40.26 | 2024 | |
| Ethicon US, LLC | $36.00 | 2025 | Vistaseal, Ethicon, Surgiflo Hemostatic Matrix |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $35.96 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $35.91 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $31.65 | 2025 | Exparel |
| Medtronic, INC. | $30.09 | 2023-2024 | Ligasure, Pteye Parathyroid Detection System |
| Acclarent, INC | $29.21 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $26.67 | 2025 | |
| Integra Lifesciences Corporation | $23.87 | 2022 | |
| Neurent Medical Limited | $23.71 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Nuvasive, INC. | $23.26 | 2021 | |
| Avita Medical Americas, LLC | $22.91 | 2025 | Cohealyx, Permeaderm, Recell |
| Pentax of America, INC. | $22.21 | 2023 | Video Naso Pharyngo Laryngostroboscope |
| Baudax Bio INC. | $19.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.